Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$13.6 | ― | 31.00% | Initiated | |||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$170 | ― | 11.70% | Initiated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$191 | ― | 7.40% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$54.4→C$4,723.8 | ― | 11.70% | Downgraded | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$40.08 | ― | 8.70% | Initiated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$50 | ― | 11.70% | Initiated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$1.29→C$1.43 | ― | 7.10% | Reiterated | ||||
Royal Bank Of Canada | BUY C$180 | ― | -4.20% | Reiterated | Barclays Reaffirms Their Buy Rating on Royal Bank Of Canada (RY) | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$193.25→C$183.23 | ― | 19.80% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$5,700 | ― | 11.70% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$186.09 | ― | 11.70% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$0.5 | ― | 8.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL C$4→C$3.3 | ― | 3.10% | Reiterated | |||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$14 | ― | 3.10% | Reiterated | |||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$24.33→C$20.04 | ― | 0.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$16.5 | ― | 2.50% | Reiterated | |||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$6.75 | ― | 15.80% | Reiterated | ||||
Lightspeed POS Inc | HOLD C$21.47→C$17.18 | ― | -3.90% | Reiterated | Stifel Nicolaus Sticks to Its Hold Rating for Lightspeed POS Inc (LSPD) | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$16 | ― | 2.50% | Reiterated | |||||
Jamieson Wellness Inc | BUY C$42 | ― | -8.90% | Reiterated | Stifel Nicolaus Keeps Their Buy Rating on Jamieson Wellness Inc (JWEL) | ||||
Royal Bank Of Canada | BUY C$195 | ― | -0.70% | Reiterated | Royal Bank of Canada: Positioned for Growth with Strategic Initiatives and AI Leverage | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$0.4 | ― | 8.50% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$17 | ― | 18.10% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$10.02 | ― | 2.00% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$3.25 | ― | 8.50% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$14→C$13.5 | ― | 9.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$3→C$3.25 | ― | 9.60% | Reiterated | |||||
BRP | BUY C$88→C$70 | ― | -9.80% | Reiterated | BRP Inc. (DOO:CN) (DOOO) PT Lowered to Cdn$70 at DA DavidsonDA Davidson analyst Brandon Rolle lowered the price target on BRP Inc. (DOO:CN) (NASDAQ: DOOO) to Cdn$70.00 (from Cdn$88.00) while maintaining a Buy rating. | ||||
Lithium Americas Corp. | BUY C$7.16 | ― | -2.30% | Reiterated | Strategic Financial Maneuvers and Project Developments Bolster Buy Rating for Lithium Americas Corp. | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$37→C$35 | ― | 5.60% | Reiterated | ||||
Jamieson Wellness Inc | BUY C$42 | ― | -1.40% | Reiterated | TD Securities Reiterates Buy Rating on Jamieson Wellness Inc. (JWEL:CN) (JWLLF)TD Securities analyst Derek Lessard reiterated a Buy rating and Cdn$42.00 price target on Jamieson Wellness Inc. (JWEL:CN) (OTC: JWLLF). | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$41 | ― | 5.90% | Reiterated | ||||
Shopify | BUY C$178.93→C$214.72 | ― | -2.00% | Reiterated | Deutsche Bank reiterates Buy Rating on Shopify (SHOP); Incrementally Positive Post Shoptalk 2025Deutsche Bank analyst Bhavin Shah reiterated a Buy rating and $150.00 price target on Shopify (NYSE: SHOP), saying they are incrementally positive post Shoptalk 2025. | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$99→C$69 | ― | 4.90% | Reiterated | |||||
Hudbay Minerals | BUY C$16 | ― | -3.20% | Reiterated | Analysts Offer Insights on Materials Companies: Itafos (Other OTC: MBCF) and Hudbay Minerals (NYSE: HBM) | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$4.25 | ― | 0.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$24.33→C$20.04 | ― | 29.90% | Reiterated | |||||
xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$18.61→C$15.75 | ― | 1.30% | Reiterated | |||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$30.06→C$22.9 | ― | 5.90% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$286.29 | ― | 10.80% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL C$90 | ― | 8.80% | Downgraded | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$2.86→C$3.94 | ― | 7.10% | Reiterated | ||||
Satellos Bioscience | BUY C$1.2 | ― | -5.50% | Reiterated | Satellos Bioscience: Buy Rating Backed by Promising Clinical Progress and Robust Financial Position | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$90.18 | ― | 19.10% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$21.47→C$20.04 | ― | 15.10% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$78→C$58 | ― | 14.90% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$4 | ― | 15.80% | Reiterated | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$28.63→C$25.77 | ― | 11.30% | Reiterated | ||||
Telus | HOLD C$22 | ― | -7.40% | Reiterated | Telus: Balancing Strategic Initiatives and Market Uncertainty with a Hold Rating | ||||
![]() | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$140 | ― | 14.90% | Reiterated |